BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14742800)

  • 1. Vardenafil treatment for erectile dysfunction.
    Crowe SM; Streetman DS
    Ann Pharmacother; 2004 Jan; 38(1):77-85. PubMed ID: 14742800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U; Gleiter CH
    Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
    Vickers MA; Satyanarayana R
    Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil: a review of its use in erectile dysfunction.
    Keating GM; Scott LJ
    Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; SaccĂ  A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE5 inhibitors: are there differences?
    Carson CC
    Can J Urol; 2006 Feb; 13 Suppl 1():34-9. PubMed ID: 16526979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
    Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
    Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of vardenafil in patients with erectile dysfunction: result of a bridging study in Japan.
    Nagao K; Ishii N; Kamidono S; Osada T;
    Int J Urol; 2004 Jul; 11(7):515-24. PubMed ID: 15242361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of vardenafil for men with erectile dysfunction].
    Zhu J; Jiang H
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):704-10. PubMed ID: 15497716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy and safety of vardenafil in difficult-to-treat erectile dysfunction men].
    Wang CH
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):377-80. PubMed ID: 16683577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
    Donatucci C; Eardley I; Buvat J; Gittelman M; Kell P; Segerson T; Homering M; Montorsi F;
    J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.
    Bischoff E
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S34-7. PubMed ID: 15224134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of phosphodiesterase-5 inhibitors.
    Corbin JD; Francis SH
    Int J Clin Pract; 2002; 56(6):453-9. PubMed ID: 12166544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.